Clinical Trials
3
Active:0
Completed:3
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers
Phase 1
Completed
- Conditions
- Renal Function Impairment in Healthy Volunteers
- Interventions
- Drug: Saline
- First Posted Date
- 2016-12-14
- Last Posted Date
- 2019-08-09
- Lead Sponsor
- veriNOS operations GmbH
- Target Recruit Count
- 16
- Registration Number
- NCT02992236
- Locations
- 🇩🇪
Universitätsklinik Erlangen, Erlangen, Germany
Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury
- First Posted Date
- 2016-06-08
- Last Posted Date
- 2021-10-11
- Lead Sponsor
- veriNOS operations GmbH
- Target Recruit Count
- 224
- Registration Number
- NCT02794168
- Locations
- 🇦🇹
Universitätsklinik für Neurochirurgie, Graz, Austria
🇦🇹Neurologie und Neurochirurgie Medizinische Universität Innsbruck, Innsbruck, Austria
🇦🇹Klinik für Allgemeine Anästhesie und Intensivmedizin AKH Wien, Wien, Austria
Phase 2 a Study to Assess Safety and Pharmacokinetics of VAS203 in Patients With Traumatic Brain Injury
- First Posted Date
- 2013-12-16
- Last Posted Date
- 2016-03-07
- Lead Sponsor
- veriNOS operations GmbH
- Target Recruit Count
- 32
- Registration Number
- NCT02012582
- Locations
- 🇦🇹
Medical University Innsbruck Department of Neurology, Innsbruck, Austria
🇫🇷HIA Sainte-Anne Boulevard Sainte-Anne, Toulon, France
🇪🇸Vall d'Hebron University Hospital Department of Neurosurgery, Barcelona, Spain
News
No news found